New anxiety drug shows promise in early trial
NCT ID NCT06653296
First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 35 times
Summary
This study tested a new drug called ENX-102 in 38 adults with generalized anxiety disorder (GAD). The goal was to see if the drug is safe and helps reduce anxiety symptoms. Participants received either ENX-102 or a placebo, and researchers monitored side effects and anxiety levels. The results will help decide if larger studies are needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERAL ANXIETY DISORDER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
MAC Clinical Research
Liverpool, UK, United Kingdom
-
MAC Clinical Research
Blackpool, United Kingdom
-
MAC Clinical Research
Manchester, United Kingdom
Conditions
Explore the condition pages connected to this study.